CVS Health close to $10.5B deal with Oak Street Health

Amy Baxter | | Health Exec | Mergers & Acquisitions

CVS Health is closing in on a deal to acquire primary care provider Oak Street Health for $10.5 billion. The news was first reported by The Wall Street Journal, which cited people with knowledge of the matter.

News of the acquisition was leaked last month when the two companies were reportedly engaging in talks. Now, CVS Health and Oak Street Health are circling a deal for a share price of $39. The deal could be announced by the companies as soon as this week if it is finalized. 

The deal is just the latest mega-deal from CVS Health. The retail pharmacy chain announced it will acquire Signify Health for $8 billion last year. Signify Health is a home health services company, while Oak Street Health is a primary care provider for Medicare beneficiaries. Both deals push CVS Health further into the healthcare provider space. The company also owns insurer Aetna, which it acquired in 2018 in the biggest healthcare deal in U.S. history.

According to the WSJ, CVS’ strategy of becoming a provider aligns with healthcare trends. CVS has positioned itself as a provider of some healthcare services for many years through its HealthHUB and Minute Clinic offerings, but through acquisitions the company can take on a much larger patient population with many more services. 

“Companies with health-insurance units, particularly those that offer Medicare Advantage plans, the private version of the federal program, have been especially interested in acquiring the clinics,” the WSJ reported. “The combinations would help the companies shave costs by managing patients more closely and in particular, helping them avoid costly hospital visits.”

See the full story below:

 

CVS Nearing $10.5 Billion Deal for Primary-Care Provider Oak Street Health

Related Content

CVS Health launches new virtual primary care service
Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

FDA approves first therapy for very rare lipid storage disorder
Report: Johnson & Johnson wants to sell its stroke business for more than $1B
Zimmer agrees to buy Paragon 28 for $1.1B
Concerns about private equity's growing influence in radiology
Philips to sell its emergency care business to private equity firm
FTC, DOJ and HHS release report warning of private equity consolidation in healthcare

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”